COVID-19 and headache

COVID-19 and headache




COVID-19, headache, trigeminovascular system


A headache is a major symptom of COVID-19 and can indicate the development of systemic and neurologic symptoms. The clinical features of headache in COVID-19 are variable and underlying mechanisms have not been established yet. It should be considered that a headache can be an isolated presenting symptom of COVID-19 and can become a persistent daily headache after recovery. We think that there is a need for future studies to evaluate headache mechanisms and the relation of headaches with other symptoms and infection severity to improve care and optimize management for COVID-19.


Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020;109:102433.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020;77(6):683-690

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1‐211.

Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005;5:718‐725.

Mutiawati E, Syahrul S, Fahriani M, Fajar JK, Mamada SS, Maliga HA, et al Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis. F1000 Res 2020;9:1316

Martelletti P, Bentivegna E, Spuntarelli V, Luciani M. Long-COVID Headache, SN Compr Clin Med. 2021;3(7):1–3.

Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203:622–630.

Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L Dubé M, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2019;12(1):14.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418.

Li W , Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426(6965):450-4.

Zhou P, Yang X, Wang X, Hu,B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020:579:270‐273.

Bolay H, Gül A, Baykan B. COVID-19 is a Real Headache! Headache. 2020;60(7):1415-1421.

Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, Goor H, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631–637.

Paula RCA, Vasconcelos TMF, Costa FBS, Brito LA, Torres DM, Moura AEF, et al Characterization of Headache in COVID-19: a Retrospective Multicenter Study. Molecular Neurobiology volume 2021;58:4487–4494.

Caronna E, Ballvé A, Llauradó A, Gallardo VJ, Ariton DM, Lallana S, et al. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40(13):1410- 1421.

Hou CC, Lin H, Chang CP, Huang WT, Lin MT. Oxidative stress and pyrogenic fever pathogenesis. Eur J Pharmacol. 2011;667(1–3): 6–12.

Lechien JR, Chiesa‐Estomba CM, Place S, Laethem YV, Cabaraux P, Mat Q, et al. Clinical and Epidemiological Characteristics of 1,420 European Patients with mild‐to‐moderate Coronavirus Disease 2019. J Intern Med. 2020;288(3):335-344

Toptan T, Aktan Ç, Başarı A, Bolay H. Case Series of Headache Characteristics in COVID‐19: Headache Can Be an Isolated Symptom. Headache 2020;60(8):1788-1792.

Souza DD, Shivde S, Awatare P, Avati A, John SK, Badachi S, et al. Headaches associated with acute SARS-CoV-2 infection: A prospective cross-sectional study. SAGE Open Med. 2021;9:20503121211050227.

Porta‐Etessam J, Matías‐Guiu JA, González‐García N, Iglesias PG, Santos‐Bueso E, Arriola-Villalobos P, et al. Spectrum of Headaches Associated With SARS‐CoV‐2 Infection: Study of Healthcare Professionals. Headache. 2020;60(8):1697-1704.

Karadaş Ö, Öztürk B, Sonkaya AR, Taşdelen B, Özge A, Bolay H, et al. Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6. Neurol Sci. 2021;9:1–9.

Membrilla JA, Lorenzo I, Sastre M, Terán JD. Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross‐Sectional Study. Headache 2020;60(10):2176-2191.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020;19;368:m606.

Tostmann A, Bradley J, Bousema T, Yiek WK, Holwerda M, Bleeker-Rovers C, et al. Strong associations and moderate predictive value of early symptoms for SARS‐CoV‐2 test positivity among healthcare workers, the Netherlands, March 2020. Euro Surveill. 2020;25:2000508.

Rocha-Filho PAS, Magalhães JE. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia. Cephalalgia 2020;40:1443–1451

Trigo J, García-Azorín D, Planchuelo-Gómez A, Martínez-Pías E, Talavera B, Hernández-Pérez I, et al. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. J Headache Pain 2020;21:94.

Uygun Ö, Ertaş M, Ekizoğlu E, Bolay H, Özge A, Orhan EK, et al. Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain 2020;21(1):121

Falkenberg K, Bjerg HR, Olesen J. Two-hour CGRP infusion causes gastrointestinal hyperactivity: possible relevance for CGRP antibody treatment. Headache. 2020;60:929–937.

Fernández-de-las-Peñas C, Gómez-Mayordomo V, Cuadrado ML, Palacios-Ceña D, Florencio LL, Guerrero AL, et al. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study. Cephalalgia. 2021;41(13):1332–1341.

Al-Hashe JY, Abokalawa F, Alenzi M, Alroughani R, Ahmed SF. Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study. J Headache Pain. 2021;22(1):97.

Tolebeyan AS, Zhang N, Cooper V, Deena E. Kuruvilla. Headache in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Narrative Review. Headache. 2020;60(10):2131-2138

Magdy R, Hussein M, Ragaie C, Abdel-Hamid HM, Khallaf A, Rizk HI, et al. Characteristics of headache attributed to COVID-19 infection and predictors of its frequency and intensity: A cross sectional study. Cephalalgia.2020;40(13): 1422–1431.

Angus-Leppan H, Guiloff AE, Benson K, Guiloff RJ. Navigating migraine care through the COVID-19 pandemic: an update Journal of Neurology 2021:268:4388–4395

López JT, García-Azorín D, Planchuelo-Gómez Á, García-Iglesias C, Dueñas-Gutiérrez C, Guerrero AL, et al. Phenotypic characterization of acute headache attributed to SARS-CoV-2: an ICHD-3 validation study on 106 hospitalized patients. Cephalalgia. 2020:40(13):1432–1442.

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270): 220–232.

Keser Şahin HH, Baş Y, Şenel, E. Analysis of cytokine and COVID-19 associated cytokine storm researches in scientific literature: A bibliometric study. The Injector. 2022;1(1):2–15.

Baber A. The effect of the COVID-19 pandemic on the psychological state of healthcare workers around the world: A review. The Injector. 2022;1(1):16–30.

Falchi D, Bakır AC, Risteski T, Abu Tziam H, Yüksel S, Inal Azizoğlu S. Diagnostic Value of The Ischemia Modified Albumin and Pentraxin 3 In Pediatric Appendicitis: A Meta Analysis. J Clin Tri Exp Invest. 2022;1(1): 1–9.

Klyuev SA, Asharur RM, Goremykin IV, Masevkin VG, Shintaev TK, Azizoğlu, M. Two Types of Gastric Volvulus In Children: Case Reports And Review of The Literature. J Clin Tri Exp Invest. 2022;1(1):10–6.

Pagotti MD, Bueno SCP, Gomes CIG, Oliveira PA de, Scanavacca MI, Hachul DT. The Importance of Adequate Programming Dual-Chamber Pacemaker in Physically Active Patients. J Clin Tri Exp Invest. 2022; 1(1):22–27.

Colman I, Friedman BW, Brown MD, Innes GD, Grafstein E, Roberts TE, et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ. 2008;336(7657):1359–61.

Morollón N, Belvís R, Dios AD, Pagès N, González-Oria C, Latorre G, et al. Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology’s Headache Study Group, Neurologia (Engl Ed). 2020;35(9):628-632.

Danser AHJ, Epstein M, Batlle D. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: at present there is no evidence to abandon Renin-Angiotensin System Blockers. Hypertension. 2020;75(6):1382-1385

Brink AM, Vries T, Danser AH. Headache medication and the COVID-19 pandemic. J Headache Pain. 2020;21(1):38.




How to Cite

Sarıcam, G. (2022). COVID-19 and headache : COVID-19 and headache . The Injector, 1(2), 84–89.